Market Closed -
Hong Kong S.E.
04:08:35 2024-05-13 am EDT
|
5-day change
|
1st Jan Change
|
7.62
HKD
|
+0.93%
|
|
+4.96%
|
+9.01%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
15,830
|
8,056
|
8,717
|
7,728
|
8,481
|
-
|
-
|
Enterprise Value (EV)
1 |
13,603
|
5,106
|
5,899
|
5,051
|
7,003
|
6,411
|
5,786
|
P/E ratio
|
48.7
x
|
17.4
x
|
18.1
x
|
14.8
x
|
14.6
x
|
12.5
x
|
10.4
x
|
Yield
|
0.29%
|
2.17%
|
2.58%
|
6.45%
|
3.43%
|
4.01%
|
4.87%
|
Capitalization / Revenue
|
30.9
x
|
11.7
x
|
11.1
x
|
8.34
x
|
7.48
x
|
6.31
x
|
5.22
x
|
EV / Revenue
|
26.6
x
|
7.4
x
|
7.5
x
|
5.45
x
|
6.18
x
|
4.77
x
|
3.56
x
|
EV / EBITDA
|
52.1
x
|
12
x
|
12.7
x
|
10.6
x
|
9.43
x
|
7.46
x
|
6.61
x
|
EV / FCF
|
67,170,395
x
|
12,611,464
x
|
24,214,430
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
5.39
x
|
2.47
x
|
2.59
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,252,208
|
1,245,177
|
1,218,573
|
1,216,312
|
1,214,821
|
-
|
-
|
Reference price
2 |
12.64
|
6.470
|
7.154
|
6.353
|
6.981
|
6.981
|
6.981
|
Announcement Date
|
3/25/21
|
3/22/22
|
3/27/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
511.5
|
690.3
|
786.4
|
926
|
1,134
|
1,345
|
1,624
|
EBITDA
1 |
261.2
|
425.8
|
466.2
|
476.5
|
742.6
|
859.1
|
875.7
|
EBIT
1 |
253
|
413.9
|
444.6
|
443.5
|
688.2
|
796.1
|
795.7
|
Operating Margin
|
49.47%
|
59.96%
|
56.54%
|
47.9%
|
60.69%
|
59.21%
|
49%
|
Earnings before Tax (EBT)
1 |
310.1
|
534.5
|
563.1
|
588.8
|
709.9
|
833.8
|
940.3
|
Net income
1 |
250.3
|
456.8
|
478.7
|
504
|
569.3
|
668.5
|
785.1
|
Net margin
|
48.93%
|
66.18%
|
60.88%
|
54.43%
|
50.2%
|
49.72%
|
48.35%
|
EPS
2 |
0.2597
|
0.3708
|
0.3963
|
0.4299
|
0.4784
|
0.5593
|
0.6700
|
Free Cash Flow
|
202.5
|
404.9
|
243.6
|
-
|
-
|
-
|
-
|
FCF margin
|
39.59%
|
58.66%
|
30.98%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
77.53%
|
95.09%
|
52.25%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
80.91%
|
88.64%
|
50.89%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0371
|
0.1401
|
0.1845
|
0.4100
|
0.2392
|
0.2797
|
0.3400
|
Announcement Date
|
3/25/21
|
3/22/22
|
3/27/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
212.6
|
298.9
|
318.1
|
372.1
|
332.3
|
454
|
403.6
|
522.4
|
477
|
658.7
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
192.5
|
221.4
|
181.9
|
262.7
|
183.7
|
259.8
|
253.4
|
356.4
|
Operating Margin
|
-
|
-
|
60.51%
|
59.5%
|
54.74%
|
57.85%
|
45.52%
|
49.73%
|
53.13%
|
54.11%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
157.7
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
47.46%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-
|
0.1614
|
0.2094
|
0.1295
|
0.2668
|
0.2173
|
0.2126
|
0.2200
|
0.2800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/25/20
|
3/25/21
|
8/26/21
|
3/22/22
|
8/25/22
|
3/27/23
|
8/29/23
|
3/20/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,227
|
2,950
|
2,818
|
2,677
|
1,478
|
2,070
|
2,695
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
203
|
405
|
244
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.3%
|
13.9%
|
14.4%
|
14.4%
|
14.8%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
13.1%
|
14.3%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
1,907
|
3,205
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
2.350
|
2.620
|
2.770
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
0.2300
|
0.3500
|
-
|
-
|
-
|
-
|
-
|
Capex
|
17.8
|
30.9
|
75.7
|
-
|
-
|
-
|
-
|
Capex / Sales
|
3.49%
|
4.47%
|
9.63%
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/21
|
3/22/22
|
3/27/23
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
6.981
CNY Average target price
9.25
CNY Spread / Average Target +32.49% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.01% | 1.17B | | +9.48% | 27.43B | | -30.09% | 3.18B | | -16.08% | 2.53B | | +19.05% | 2.49B | | +11.11% | 2.16B | | -4.24% | 2.03B | | +5.56% | 1.61B | | +3.25% | 1.31B | | +29.73% | 1.29B |
Medical Supplies
|